Rhythm Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of RYTM for the last quarter is 24.23 M USD, and it's 7.69% higher compared to the previous quarter. The net income of Q4 23 is -41.62 M USD.